Disc Medicine, Inc. (IRON)
68.42
-0.07
(-0.10%)
USD |
NASDAQ |
Sep 22, 16:00
68.42
0.00 (0.00%)
After-Hours: 19:23
Disc Medicine Debt to Equity Ratio : 0.0945 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0945 |
| March 31, 2026 | 0.0451 |
| December 31, 2025 | 0.0419 |
| September 30, 2025 | 0.054 |
| June 30, 2025 | 0.0503 |
| March 31, 2025 | 0.0464 |
| December 31, 2024 | 0.0676 |
| September 30, 2024 | 0.0038 |
| June 30, 2024 | 0.0038 |
| March 31, 2024 | 0.006 |
| December 31, 2023 | 0.0061 |
| September 30, 2023 | 0.0055 |
| June 30, 2023 | 0.0056 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.0054 |
| December 31, 2022 | 0.0076 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.0273 |
| March 31, 2022 | 0.0373 |
| December 31, 2021 | 0.0213 |
| September 30, 2021 | 0.0472 |
| June 30, 2021 | 0.05 |
| March 31, 2021 | 0.0533 |
| December 31, 2020 | -0.9899 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Recursion Pharmaceuticals, Inc. | 0.0728 |
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 735.07M |
| Total Liabilities (Quarterly) | 90.91M |
| Shareholders Equity (Quarterly) | 644.16M |
| Current Ratio | 24.14 |
| Net Debt Paydown Yield | -0.22% |